US Stock MarketDetailed Quotes

VistaGen Therapeutics (VTGN)

Watchlist
  • 0.5939
  • +0.0239+4.19%
Close Apr 24 16:00 ET
  • 0.5729
  • -0.0210-3.54%
Post 20:01 ET
23.53MMarket Cap-0.31P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

VistaGen Therapeutics (VTGN) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-71.51%-17.63M
-26.39%-13.76M
-73.39%-18.85M
-63.08%-42.1M
-44.05%-10.06M
-116.56%-10.28M
-75.86%-10.89M
-37.74%-10.87M
48.08%-25.81M
6.54%-6.99M
Net income from continuing operations
-34.14%-18.9M
-49.81%-19.42M
-40.64%-15.1M
-75.12%-51.42M
-43.21%-13.64M
-121.87%-14.09M
-96.74%-12.96M
-55.48%-10.73M
50.44%-29.36M
22.13%-9.52M
Operating gains losses
----
----
----
----
----
----
----
----
-92.31%6K
----
Depreciation and amortization
17.39%189K
17.83%185K
11.92%169K
11.80%635K
12.93%166K
12.59%161K
12.95%157K
8.63%151K
6.77%568K
6.60%147K
Other non cash items
---1K
---1K
--3K
----
----
----
----
----
----
----
Change In working capital
-95.28%126K
378.12%4.52M
-230.11%-4.71M
500.25%4.76M
38.21%2.57M
180.17%2.67M
391.08%946K
15.80%-1.43M
-60.88%793K
308.92%1.86M
-Change in prepaid assets
-71.28%284K
1,608.65%1.78M
-100.62%-1.94M
-135.20%-88K
-543.75%-213K
1,236.78%989K
-79.07%104K
-365.38%-968K
-92.16%250K
-68.02%48K
-Change in payables and accrued expense
-85.14%294K
166.08%3.2M
-432.75%-2.42M
988.31%5.68M
54.23%2.96M
635.32%1.98M
367.33%1.2M
62.49%-455K
155.89%522K
232.93%1.92M
-Change in other current assets
----
----
-119.47%-37K
----
----
----
----
--190K
----
----
-Change in other current liabilities
-96.30%-159K
-10.20%-216K
33.85%-86K
-23.43%-611K
-50.00%-204K
35.20%-81K
-63.33%-196K
-14.04%-130K
-14.32%-495K
-21.97%-136K
-Change in other working capital
-35.65%-293K
-1,204.00%-276K
-246.15%-225K
-143.02%-222K
3.03%34K
-124.11%-216K
109.92%25K
59.63%-65K
150.49%516K
120.75%33K
Cash from discontinued investing activities
Operating cash flow
-71.51%-17.63M
-26.39%-13.76M
-73.39%-18.85M
-63.08%-42.1M
-44.05%-10.06M
-116.56%-10.28M
-75.86%-10.89M
-37.74%-10.87M
48.08%-25.81M
6.54%-6.99M
Investing cash flow
Cash flow from continuing investing activities
124.64%104K
98.79%-94K
85.59%-788K
-21,454.10%-13.15M
1,917.24%527K
-1,218.75%-422K
-7.79M
-5.47M
91.76%-61K
94.51%-29K
Net PPE purchase and sale
---26K
1.64%-60K
-54.76%-65K
-213.11%-191K
-203.45%-88K
--0
---61K
---42K
71.23%-61K
---29K
Net business purchase and sale
----
----
----
----
----
----
----
----
--0
----
Net investment purchase and sale
130.81%130K
99.56%-34K
86.67%-723K
---12.96M
--615K
---422K
---7.73M
---5.43M
--0
--0
Cash from discontinued investing activities
Investing cash flow
124.64%104K
98.79%-94K
85.59%-788K
-21,454.10%-13.15M
1,917.24%527K
-1,218.75%-422K
---7.79M
---5.47M
91.76%-61K
94.51%-29K
Financing cash flow
Cash flow from continuing financing activities
80.36%2.11M
27.65M
1,590.91%1.49M
-97.50%3.21M
613.42%1.95M
-98.75%1.17M
0
-89.94%88K
12,434.49%128.4M
4.38%-380K
Net issuance payments of debt
---278K
---274K
--930K
--0
--0
--0
--0
--0
4.74%-985K
--0
Net common stock issuance
119.28%2.32M
--27.93M
--397K
-97.67%3.01M
612.07%1.95M
-98.87%1.06M
--0
--0
184,927.14%129.38M
-349.29%-381K
Proceeds from stock option exercised by employees
-38.05%70K
--0
82.95%161K
2,412.50%201K
--0
3,666.67%113K
--0
2,100.00%88K
-87.30%8K
1,100.00%1K
Cash from discontinued financing activities
Financing cash flow
80.36%2.11M
--27.65M
1,590.91%1.49M
-97.50%3.21M
613.42%1.95M
-98.75%1.17M
--0
-89.94%88K
12,434.49%128.4M
4.38%-380K
Net cash flow
Beginning cash position
-25.47%62.79M
-52.40%48.99M
-43.67%67.13M
616.23%119.17M
-40.96%74.72M
124.01%84.25M
969.61%102.92M
616.23%119.17M
-75.58%16.64M
405.49%126.56M
Current changes in cash
-61.74%-15.42M
173.91%13.8M
-11.68%-18.15M
-150.75%-52.04M
-2.57%-7.58M
-110.71%-9.53M
-166.72%-18.67M
-131.58%-16.25M
299.10%102.53M
11.97%-7.39M
End cash Position
-36.60%47.37M
-25.47%62.79M
-52.40%48.99M
-43.67%67.13M
-43.67%67.13M
-40.96%74.72M
124.01%84.25M
969.61%102.92M
616.23%119.17M
616.23%119.17M
Free cash flow
-71.76%-17.66M
-26.24%-13.82M
-73.32%-18.91M
-63.44%-42.29M
-44.71%-10.15M
-115.11%-10.28M
-76.85%-10.95M
-38.27%-10.91M
48.18%-25.87M
6.15%-7.01M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Dec 31, 2025(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -71.51%-17.63M-26.39%-13.76M-73.39%-18.85M-63.08%-42.1M-44.05%-10.06M-116.56%-10.28M-75.86%-10.89M-37.74%-10.87M48.08%-25.81M6.54%-6.99M
Net income from continuing operations -34.14%-18.9M-49.81%-19.42M-40.64%-15.1M-75.12%-51.42M-43.21%-13.64M-121.87%-14.09M-96.74%-12.96M-55.48%-10.73M50.44%-29.36M22.13%-9.52M
Operating gains losses ---------------------------------92.31%6K----
Depreciation and amortization 17.39%189K17.83%185K11.92%169K11.80%635K12.93%166K12.59%161K12.95%157K8.63%151K6.77%568K6.60%147K
Other non cash items ---1K---1K--3K----------------------------
Change In working capital -95.28%126K378.12%4.52M-230.11%-4.71M500.25%4.76M38.21%2.57M180.17%2.67M391.08%946K15.80%-1.43M-60.88%793K308.92%1.86M
-Change in prepaid assets -71.28%284K1,608.65%1.78M-100.62%-1.94M-135.20%-88K-543.75%-213K1,236.78%989K-79.07%104K-365.38%-968K-92.16%250K-68.02%48K
-Change in payables and accrued expense -85.14%294K166.08%3.2M-432.75%-2.42M988.31%5.68M54.23%2.96M635.32%1.98M367.33%1.2M62.49%-455K155.89%522K232.93%1.92M
-Change in other current assets ---------119.47%-37K------------------190K--------
-Change in other current liabilities -96.30%-159K-10.20%-216K33.85%-86K-23.43%-611K-50.00%-204K35.20%-81K-63.33%-196K-14.04%-130K-14.32%-495K-21.97%-136K
-Change in other working capital -35.65%-293K-1,204.00%-276K-246.15%-225K-143.02%-222K3.03%34K-124.11%-216K109.92%25K59.63%-65K150.49%516K120.75%33K
Cash from discontinued investing activities
Operating cash flow -71.51%-17.63M-26.39%-13.76M-73.39%-18.85M-63.08%-42.1M-44.05%-10.06M-116.56%-10.28M-75.86%-10.89M-37.74%-10.87M48.08%-25.81M6.54%-6.99M
Investing cash flow
Cash flow from continuing investing activities 124.64%104K98.79%-94K85.59%-788K-21,454.10%-13.15M1,917.24%527K-1,218.75%-422K-7.79M-5.47M91.76%-61K94.51%-29K
Net PPE purchase and sale ---26K1.64%-60K-54.76%-65K-213.11%-191K-203.45%-88K--0---61K---42K71.23%-61K---29K
Net business purchase and sale ----------------------------------0----
Net investment purchase and sale 130.81%130K99.56%-34K86.67%-723K---12.96M--615K---422K---7.73M---5.43M--0--0
Cash from discontinued investing activities
Investing cash flow 124.64%104K98.79%-94K85.59%-788K-21,454.10%-13.15M1,917.24%527K-1,218.75%-422K---7.79M---5.47M91.76%-61K94.51%-29K
Financing cash flow
Cash flow from continuing financing activities 80.36%2.11M27.65M1,590.91%1.49M-97.50%3.21M613.42%1.95M-98.75%1.17M0-89.94%88K12,434.49%128.4M4.38%-380K
Net issuance payments of debt ---278K---274K--930K--0--0--0--0--04.74%-985K--0
Net common stock issuance 119.28%2.32M--27.93M--397K-97.67%3.01M612.07%1.95M-98.87%1.06M--0--0184,927.14%129.38M-349.29%-381K
Proceeds from stock option exercised by employees -38.05%70K--082.95%161K2,412.50%201K--03,666.67%113K--02,100.00%88K-87.30%8K1,100.00%1K
Cash from discontinued financing activities
Financing cash flow 80.36%2.11M--27.65M1,590.91%1.49M-97.50%3.21M613.42%1.95M-98.75%1.17M--0-89.94%88K12,434.49%128.4M4.38%-380K
Net cash flow
Beginning cash position -25.47%62.79M-52.40%48.99M-43.67%67.13M616.23%119.17M-40.96%74.72M124.01%84.25M969.61%102.92M616.23%119.17M-75.58%16.64M405.49%126.56M
Current changes in cash -61.74%-15.42M173.91%13.8M-11.68%-18.15M-150.75%-52.04M-2.57%-7.58M-110.71%-9.53M-166.72%-18.67M-131.58%-16.25M299.10%102.53M11.97%-7.39M
End cash Position -36.60%47.37M-25.47%62.79M-52.40%48.99M-43.67%67.13M-43.67%67.13M-40.96%74.72M124.01%84.25M969.61%102.92M616.23%119.17M616.23%119.17M
Free cash flow -71.76%-17.66M-26.24%-13.82M-73.32%-18.91M-63.44%-42.29M-44.71%-10.15M-115.11%-10.28M-76.85%-10.95M-38.27%-10.91M48.18%-25.87M6.15%-7.01M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -